AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 187 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2024. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,057,777 | +48.2% | 24,531 | +0.5% | 0.00% | – |
| Q1 2024 | $713,953 | +98.9% | 24,417 | +51.5% | 0.00% | – |
| Q4 2023 | $358,881 | -23.9% | 16,115 | -15.5% | 0.00% | – |
| Q3 2023 | $471,785 | -6.1% | 19,062 | +7.4% | 0.00% | – |
| Q2 2023 | $502,623 | +38.9% | 17,748 | +12.7% | 0.00% | – |
| Q1 2023 | $361,732 | -12.9% | 15,748 | +6.4% | 0.00% | – |
| Q4 2022 | $415,444 | +1.1% | 14,795 | +1.9% | 0.00% | – |
| Q3 2022 | $411,000 | +74.9% | 14,517 | +37.0% | 0.00% | – |
| Q2 2022 | $235,000 | +2.2% | 10,595 | +34.2% | 0.00% | – |
| Q1 2022 | $230,000 | +9.0% | 7,895 | +72.6% | 0.00% | – |
| Q3 2021 | $211,000 | -37.8% | 4,573 | -25.6% | 0.00% | – |
| Q2 2021 | $339,000 | +64.6% | 6,146 | +54.1% | 0.00% | – |
| Q1 2021 | $206,000 | -13.4% | 3,989 | -10.2% | 0.00% | – |
| Q2 2020 | $238,000 | -2.5% | 4,441 | -13.1% | 0.00% | – |
| Q4 2019 | $244,000 | +960.9% | 5,109 | +1751.1% | 0.00% | – |
| Q2 2018 | $23,000 | +9.5% | 276 | +5.3% | 0.00% | – |
| Q1 2018 | $21,000 | +75.0% | 262 | +23.6% | 0.00% | – |
| Q4 2017 | $12,000 | 0.0% | 212 | +14.6% | 0.00% | – |
| Q3 2017 | $12,000 | +100.0% | 185 | +54.2% | 0.00% | – |
| Q2 2017 | $6,000 | +20.0% | 120 | +23.7% | 0.00% | – |
| Q1 2017 | $5,000 | +400.0% | 97 | +361.9% | 0.00% | – |
| Q4 2016 | $1,000 | -99.1% | 21 | -99.2% | 0.00% | – |
| Q2 2016 | $106,000 | -5.4% | 2,542 | -8.2% | 0.00% | – |
| Q1 2016 | $112,000 | -17.6% | 2,769 | +32.6% | 0.00% | -100.0% |
| Q4 2015 | $136,000 | -0.7% | 2,089 | +7.3% | 0.00% | 0.0% |
| Q3 2015 | $137,000 | -31.8% | 1,947 | +7.9% | 0.00% | 0.0% |
| Q2 2015 | $201,000 | – | 1,805 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caligan Partners LP | 514,711 | $22,194,338 | 5.19% |
| ACUTA CAPITAL PARTNERS, LLC | 78,700 | $3,393,544 | 2.86% |
| Bellevue Group AG | 3,879,548 | $167,286,110 | 2.72% |
| Parkman Healthcare Partners LLC | 446,416 | $19,249,458 | 2.58% |
| Eagle Health Investments LP | 330,830 | $14,265,390 | 2.50% |
| SECTOR GAMMA AS | 121,844 | $5,253,913 | 1.96% |
| Frazier Life Sciences Management, L.P. | 871,974 | $37,599,519 | 1.76% |
| BVF INC/IL | 1,190,107 | $51,317,414 | 1.44% |
| Rock Springs Capital Management LP | 1,044,261 | $45,028,534 | 1.36% |
| FARALLON CAPITAL MANAGEMENT LLC | 5,654,502 | $243,822,126 | 1.15% |